Our Vision We aim at changing the way drug development research is done today by providing in-vitro models that reproduce the in-vivo environment in an unprecedented way. These in-vitro models, called organ-on-chips, will make it possible to better predict drugs’ responses in humans than standard in-vitro and in-vivo models and as a consequence to importantly reduce animal testing. Our Mission AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.
View Top Employees from AlveoliXWebsite | http://www.alveolix.com/ |
Revenue | $3 million |
Employees | 15 (15 on RocketReach) |
Founded | 2019 |
Address | 50 C/o Artorg Center Ch, Bern, Bern 3008, CH |
Technologies |
JavaScript,
HTML,
PHP
+17 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Drug Discovery, Business Services, Science and Engineering, Pharmaceuticals, Life Science, Manufacturing |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular AlveoliX employee's phone or email?
The AlveoliX annual revenue was $3 million in 2024.
15 people are employed at AlveoliX.
AlveoliX is based in Bern, Bern.
The NAICS codes for AlveoliX are [541713, 54171, 54, 541, 5417].
The SIC codes for AlveoliX are [87, 873].